Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ARDX | ARDELYX, INC. | Chief Medical Officer | $2.3M | -$1.57M | -40.6% | Jun 5, 2024 |
ELVN | Enliven Therapeutics, Inc. | Director | Jun 2, 2022 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|